As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.
9 Analysts have issued a NeuroBo Pharmaceuticals Inc forecast:
9 Analysts have issued a NeuroBo Pharmaceuticals Inc forecast:
| Jun '25 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -20 -20 |
24%
24%
|
|
| EBIT (Operating Income) EBIT | -20 -20 |
24%
24%
|
|
| Net Profit | -18 -18 |
29%
29%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders. The company was founded on October 30, 2014 and is headquartered in Boston, MA.
| Head office | United States |
| CEO | Hyung-Heon Kim |
| Founded | 2014 |
| Website | metaviatx.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


